KR

Kevin Richardson

Interim CEO/CFO & Board Member

Qualigen Inc.

Boston, Massachusetts


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Qualigen Inc.
Industry
research
Employees
34.0
Seniority
C suite

Technologies

Outlook GoDaddy Hosting Mobile Friendly WordPress.org Varnish Google Tag Manager Apache Gravity Forms Vimeo Google Font API AI Render

Keywords

biotechnology: pharmaceutical preparations health care biotechnology research cancer treatments oncology therapeutics qn-302 pan-ras clinical trials small molecule drugs cancer cell proliferation investigational drugs rare cancers adult cancer pediatric cancer drug development fda approval phase 1 studies novel drug candidates anti-tumor activity chemo-resistant cancers biomarkers molecular targeting gene expression regulation transcription inhibitors apoptosis mechanism of action ras mutations kras inhibitors tumor models pharmacodynamics pharmacokinetics safety studies orphan drug designation onco-targeted therapies protein-protein interaction inhibitors g4 ligands xtandi gemcitabine tumor inhibition solid tumors clinical efficacy therapeutic outcomes cancer research growth inhibition multi-center studies future studies drug efficacy biopharmaceutical innovation patient advocacy therapeutic pipeline medical oncologist health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans